Pfizer CEO Says He ‘Wouldn't Worry Much' About Monkeypox; Cuts Drug Prices for Low-Income Countries

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Pfizer’s CEO said Wednesday that he “wouldn’t worry much” about a recent monkeypox outbreak that has seen cases surge in non-endemic countries.

World's poorest countries to receive medicines at cost

Also included in the list are the company's Covid-19 treatment Paxlovid and breast cancer drug Ibrance, as well as pneumonia vaccine Prevnar 13, rheumatoid arthritis drug Xeljanz and cancer treatments Xalkori and Inlyta.Xinhua News Agency | Xinhua News Agency | Getty Images Through the program, Pfizer said it aims to improve the ease and speed of access to vital medicines for poorer nations.

"Today we are going to achieve that," he said, adding that shareholders"should think that we are doing the right thing."According to the Bill & Melinda Gates Foundation, it can typically take four to seven years longer for new treatments to become available in low-income countries than in advanced economies — if they become available at all.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

We should all collectively agree that wisdom dictates we evaulate whatever any given CEO says, find the opposite= believe that. Capitalism is organized theft and greed for powerful people. We can do better my fellow Americans. Why do we accept the ideas of 1776= still best?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 545. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots. Only a fool would give this poison to their kids. Now we need a Monkeypox Vaxx! How at-risk are children younger than 5 from serious hospitalization or death due to COVID?
Source: clevelanddotcom - 🏆 301. / 63 Read more »

Pfizer says 3 COVID shots protect children under 5Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week. Please stop pushing this anti science propaganda
Source: cleveland19news - 🏆 70. / 68 Read more »

Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced this morning.
Source: SpectrumNews1TX - 🏆 333. / 59 Read more »

Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Source: WBUR - 🏆 274. / 63 Read more »

3 doses of COVID vaccine are effective for kids under 5, Pfizer saysThe long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination. A 7 year old boy in Seattle died of heart attack with blood clots in his coronary artery & liver 13 days after receiving the Pfizer CV Vaccine
Source: TODAYshow - 🏆 389. / 55 Read more »

Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in… Incorrect.
Source: ladailynews - 🏆 332. / 59 Read more »